Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure. (Q48442845)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19803419%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19803419%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

main subject

heart failure

0 references

chronic heart failure

1 reference

Aldo Clerico

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19803419%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Marianna Fontana

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19803419%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Andrea Ripoli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19803419%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Michele Emdin

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19803419%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19803419%20AND%20SRC:MED&resulttype=core&format=json

Advances in Clinical Chemistry

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19803419%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19803419%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

163-179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19803419%20AND%20SRC:MED&resulttype=core&format=json

Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Old and new biomarkers of heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Monitoring the response to pharmacologic therapy in patients with stable chronic heart failure: is BNP or NT-proBNP a useful assessment tool?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Gene expression, processing, and secretion of natriuretic peptides: physiologic and diagnostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Cardiac natriuretic peptides gene expression and secretion in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Stretch-induced hypertrophic growth of cardiocytes and processing of brain-type natriuretic peptide are controlled by proprotein-processing endoprotease furin.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

The precursor to B-type natriuretic peptide is an O-linked glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Quality specifications for B-type natriuretic peptide assays.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

BNP in hormone-guided treatment of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

New and emerging biomarkers of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Brain natriuretic peptide-guided therapy for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Individualized treatment of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Atrial natriuretic peptide levels in congestive heart failure in man before and during converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Antihypertensive therapy reduces increased plasma levels of adrenomedullin and brain natriuretic peptide concomitant with regression of left ventricular hypertrophy in a patient with malignant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Effect of beta-blocker on left ventricular function and natriuretic peptides in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Pro-B-type natriuretic peptide levels in acute decompensated heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

Admission NT-proBNP levels, renal insufficiency and age as predictors of mortality in elderly patients hospitalized for acute dyspnea

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2809%2948007-7

7 January 2021

10.1016/S0065-2423(09)48007-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19803419%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference